The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars

NCT04034615 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The pandemic resulted in no enrollments。

Conditions

Cicatrix

Interventions

BIOLOGICAL: Mesenchyme Stem Cells low-dose group
BIOLOGICAL: Mesenchyme Stem Cells high-dose group
BIOLOGICAL: Placebo

Sponsor

Maternal and Child Health Hospital of Foshan